Wilma Knol

3.4k total citations · 1 hit paper
70 papers, 1.5k citations indexed

About

Wilma Knol is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Wilma Knol has authored 70 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Geriatrics and Gerontology, 21 papers in Economics and Econometrics and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Wilma Knol's work include Pharmaceutical Practices and Patient Outcomes (40 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers) and Medication Adherence and Compliance (12 papers). Wilma Knol is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (40 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers) and Medication Adherence and Compliance (12 papers). Wilma Knol collaborates with scholars based in Netherlands, Belgium and Switzerland. Wilma Knol's co-authors include Rob J. van Marum, Paul A. F. Jansen, Toine C. G. Egberts, Denis O’Mahony, Nicolas Rodondi, Alfred F.A.M. Schobben, A. Clara Drenth‐van Maanen, Patrick C. Souverein, Olivia Dalleur and Jean‐Baptiste Beuscart and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stroke.

In The Last Decade

Wilma Knol

64 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STOPP/START criteria for potentially inappropriate prescribing in older people: version 3

2023 216 citations Denis O’Mahony, Antonio Cherubini et al. European Geriatric Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wilma Knol Netherlands	20	811	428	294	264	217	70	1.5k
Piia Lavikainen Finland	22	558 0.7×	314 0.7×	425 1.4×	144 0.5×	244 1.1×	78	1.5k
Paul A. F. Jansen Netherlands	23	797 1.0×	372 0.9×	454 1.5×	281 1.1×	272 1.3×	57	1.7k
Beatrice Gasperini Italy	14	638 0.8×	323 0.8×	157 0.5×	157 0.6×	140 0.6×	32	1.0k
Lisa Kouladjian O’Donnell Australia	16	791 1.0×	453 1.1×	149 0.5×	208 0.8×	198 0.9×	45	955
Jonas W. Wastesson Sweden	18	726 0.9×	426 1.0×	157 0.5×	194 0.7×	285 1.3×	53	1.3k
Carlos Rojas‐Fernandez Canada	20	561 0.7×	347 0.8×	270 0.9×	133 0.5×	185 0.9×	60	1.7k
Thierry Christiaens Belgium	23	743 0.9×	403 0.9×	376 1.3×	232 0.9×	144 0.7×	81	1.8k
Robert L. Maher United States	7	954 1.2×	475 1.1×	133 0.5×	273 1.0×	291 1.3×	13	1.4k
John D. Barratt Australia	18	661 0.8×	357 0.8×	124 0.4×	194 0.7×	252 1.2×	34	1.3k
Christian Swine Belgium	16	1.4k 1.7×	682 1.6×	202 0.7×	320 1.2×	212 1.0×	44	2.0k

Countries citing papers authored by Wilma Knol

Since Specialization

Citations

This map shows the geographic impact of Wilma Knol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilma Knol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilma Knol more than expected).

Fields of papers citing papers by Wilma Knol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilma Knol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilma Knol. The network helps show where Wilma Knol may publish in the future.

Co-authorship network of co-authors of Wilma Knol

This figure shows the co-authorship network connecting the top 25 collaborators of Wilma Knol. A scholar is included among the top collaborators of Wilma Knol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilma Knol. Wilma Knol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haverkamp, Margje H., et al.. (2025). Adherence to Guideline-Directed Medical Therapy in Hospitalized Older People with Heart Failure at Discharge and 3-Month Follow-Up. Journal of Clinical Medicine. 14(19). 6928–6928.

Rosse, Floor van, Ben Janssen, Wilma Knol, et al.. (2025). The impact of summative, formative or programmatic assessment on the Dutch National Pharmacotherapy assessment: A retrospective multicentre study. European Journal of Pharmacology. 989. 177267–177267. 2 indexed citations

Knol, Wilma, Ariël M. Vondeling, Noortje van Herwaarden, et al.. (2025). Older patients’ experiences and needs regarding pharmacotherapeutic care in-hospital and after discharge. Patient Education and Counseling. 136. 108754–108754.

Blum, Manuel R., Nicolas Rodondi, Bastiaan Theodoor Gerard Marie Sallevelt, et al.. (2024). Antipsychotic prescribing and drug-related readmissions in multimorbid older inpatients: a post-hoc analysis of the OPERAM population. International Journal of Clinical Pharmacy. 46(3). 656–664.

Cherubini, Antonio, Michael Denkinger, Wilma Knol, & Aðalsteinn Guðmundsson. (2024). How to improve drug evaluation in older patients: The perspective of the European Geriatric Medicine Society ( EuGMS ). Journal of the American Geriatrics Society. 72(9). 2928–2932. 2 indexed citations

Karapinar‐Çarkit, Fatma, Marcel L. Bouvy, Svetlana V. Belitser, et al.. (2024). The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy. European Geriatric Medicine. 15(6). 1713–1723. 5 indexed citations

Kempen, Thomas, Carole E. Aubert, Huiberdina L. Koek, et al.. (2023). Drug‐related readmissions in older hospitalized adults: External validation and updating of OPERAM DRA prediction tool. Journal of the American Geriatrics Society. 71(12). 3848–3856. 1 indexed citations

Saint‐Hubert, Marie de, Séverine Henrard, Carole E. Aubert, et al.. (2023). Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial. Drugs & Aging. 40(6). 551–561. 5 indexed citations

Knol, Wilma, Michiel Voskuil, Adriaan O. Kraaijeveld, et al.. (2023). Association between perioperative statin treatment and short-term clinical outcomes following transcatheter aortic valve implantation: a retrospective cohort study. Open Heart. 10(2). e002348–e002348.

10.

Aubert, Carole E., Manuel R. Blum, Olivia Dalleur, et al.. (2023). Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study. CMAJ Open. 11(1). E170–E178. 9 indexed citations

11.

O’Mahony, Denis, Antonio Cherubini, Anna Renom‐Guiteras, et al.. (2023). STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. European Geriatric Medicine. 14(4). 625–632. 216 indexed citations breakdown →

12.

Brinkman, David J., Floor van Rosse, Ben Janssen, et al.. (2023). The impact of a summative national prescribing assessment and curriculum type on the development of the prescribing competence of junior doctors. European Journal of Clinical Pharmacology. 79(12). 1613–1621. 6 indexed citations

13.

Pandit, Rahul, David J. Brinkman, Michiel A. van Agtmael, et al.. (2022). The Dutch list of essential drugs for undergraduate medical education: A modified Delphi study. British Journal of Clinical Pharmacology. 89(4). 1431–1451. 2 indexed citations

14.

Brinkman, David J., Floor van Rosse, Ben Janssen, et al.. (2022). Do we become better prescribers after graduation: A 1‐year international follow‐up study among junior doctors. British Journal of Clinical Pharmacology. 88(12). 5218–5226. 14 indexed citations

15.

Baretella, Oliver, Martin Feller, Cinzia Del Giovane, et al.. (2021). Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients. PLoS ONE. 16(11). e0260112–e0260112. 1 indexed citations

16.

Bretagne, Lisa, Huiberdina L. Koek, Sofia Tsokani, et al.. (2021). Medication review interventions to reduce hospital readmissions in older people. Journal of the American Geriatrics Society. 69(6). 1646–1658. 54 indexed citations

17.

Hansen, Christina Raae, Denis O’Mahony, Patricia M. Kearney, et al.. (2018). Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 84(12). 2716–2728. 49 indexed citations

18.

Knol, Wilma, et al.. (2015). [Detecting inappropriate medication in older people: the revised STOPP/START criteria].. PubMed. 159. A8904–A8904. 11 indexed citations

19.

Knol, Wilma, Rob J. van Marum, Paul A. F. Jansen, et al.. (2013). Genetic Variation and the Risk of Haloperidol-Related Parkinsonism in Elderly Patients. Journal of Clinical Psychopharmacology. 33(3). 405–410. 12 indexed citations

20.

Knol, Wilma, Rob J. van Marum, Paul A. F. Jansen, Toine C. G. Egberts, & Alfred F.A.M. Schobben. (2012). Parkinsonism in Elderly Users of Haloperidol. Journal of Clinical Psychopharmacology. 32(5). 688–693. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact